Lv0
0 积分 2021-04-06 加入
Elements of cancer immunity and the cancer–immune set point
3天前
已完结
TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
3天前
已完结
Bispecific antibodies: a mechanistic review of the pipeline
18天前
已完结
The present and future of bispecific antibodies for cancer therapy
18天前
已完结
Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer
24天前
已完结
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer
1个月前
已完结
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
1个月前
已完结
Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial
1个月前
已完结
[Play the "combo fist" in the diagnosis and treatment of advanced gastric cancer]
1个月前
已完结
Relationship Between Programmed Death Ligand 1 Expression and Other Clinicopathological Features in a Large Cohort of Gastric Cancer Patients
2个月前
已完结
皖公网安备34019202002308
